Calyxt (NASDAQ: CLXT)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Calyxt (NASDAQ: CLXT) through any online brokerage.
The latest price target for Calyxt (NASDAQ: CLXT) was reported by Canaccord Genuity on Friday, March 4, 2022. The analyst firm set a price target for 4.00 expecting CLXT to rise to within 12 months (a possible 1189.91% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Calyxt (NASDAQ: CLXT) is $0.3101 last updated May 20, 2022, 8:00 PM UTC.
There are no upcoming dividends for Calyxt.
Calyxt’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Calyxt.
Calyxt is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.